GeN is a drug discovery and pre-clinical validation company with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities with an innovative drug screening technology and a development-stage drug candidate.

Through our 10+ years of experience, our team of talented scientists have developed innovative AI-driven drug discovery platforms and analytical tools leading to partnerships and numerous drug candidates in clinical trials.